外科医生主导开窗腔内主动脉修复术编码计费与合同谈判可提高医疗中心贡献边际和医生报酬
本研究分析2011至2015年63例开窗腔内主动脉修复术(FEVAR)的财务数据,发现由血管外科医生主导编码、计费和合同谈判后,医疗中心总贡献边际(CM)达492,521美元,医生平均每例报酬从1601美元增至2480美元,拒付率从50%降至0%,2015年与CMS谈判后医生报酬进一步增加27%至每例3068美元。
要点
- FEVAR索引住院产生正贡献边际251,160美元,总CM为492,521美元。
- 医生平均每例报酬从2011年1601美元增至2015年2480美元,拒付率从50%降至0%。
- 2015年与CMS谈判后医生报酬增加27%至每例3068美元,较2011年增加91%。
核心结论
- 医生主导FEVAR编码、计费和合同谈判可实现医疗中心正贡献边际并提高医生报酬。
研究设计与样本
- 单中心回顾性财务分析,纳入2011至2015年63例FEVAR手术,由具有医疗财务经验的血管外科医生管理计费编码,财务分析由UMass财务部门执行。
主要发现
- 63例FEVAR索引住院直接成本2,776,726美元,报销3,027,887美元,贡献边际251,160美元。
- 后续相关住院手术(n=26)贡献边际144,473美元,门诊就诊、影像和血管实验室检查额外贡献96,888美元。
- 所有FEVAR服务总医疗中心贡献边际为492,521美元。
- 医生平均每例报销从2011年1601美元增至2015年2480美元,拒付率从50%降至0%。
- 2015年与CMS谈判后医生报销增加27%至每例3068美元,较2011年增加91%;助理医生报销从266美元增至764美元。
关键数值与推荐
- 直接成本中移植物占55%,耗材占12%,床位占12%,手术室占10%。
临床怎么用
- 血管外科医生应主动参与FEVAR的编码、计费和合同谈判,以改善医疗中心财务表现和医生报酬。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fenestrated endovascular aneurysm repair (FEVAR) allows endovascular treatment of thoracoabdominal and juxtarenal aneurysms previously outside the indications of use for standard devices. However, because of considerable device costs and increased procedure time, FEVAR is thought to result in financial losses for medical centers and physicians. We hypothesized that surgeon leadership in the coding, billing, and contractual negotiations for FEVAR procedures will increase medical center contribution margin (CM) and physician reimbursement. METHODS: At the UMass Memorial Center for Complex Aortic Disease, a vascular surgeon with experience in medical finances is supported to manage the billing and coding of FEVAR procedures for medical center and physician reimbursement. A comprehensive financial analysis was performed for all FEVAR procedures (2011-2015), independent of insurance status, patient presentation, or type of device used. Medical center CM (actual reimbursement minus direct costs) was determined for each index FEVAR procedure and for all related subsequent procedures, inpatient or outpatient, 3 months before and 1 year subsequent to the index FEVAR procedure. Medical center CM for outpatient clinic visits, radiology examinations, vascular laboratory studies, and cardiology and pulmonary evaluations related to FEVAR were also determined. Surgeon reimbursement for index FEVAR procedure, related adjunct procedures, and assistant surgeon reimbursement were also calculated. All financial analyses were performed and adjudicated by the UMass Department of Finance. RESULTS: The index hospitalization for 63 FEVAR procedures incurred $2,776,726 of direct costs and generated $3,027,887 in reimbursement, resulting in a positive CM of $251,160. Subsequent related hospital procedures (n = 26) generated a CM of $144,473. Outpatient clinic visits, radiologic examinations, and vascular laboratory studies generated an additional CM of $96,888. Direct cost analysis revealed that grafts accounted for the largest proportion of costs (55%), followed by supplies (12%), bed (12%), and operating room (10%). Total medical center CM for all FEVAR services was $492,521. Average surgeon reimbursements per FEVAR from 2011 to 2015 increased from $1601 to $2480 while the surgeon payment denial rate declined from 50% to 0%. Surgeon-led negotiations with the Centers for Medicare & Medicaid Services during 2015 resulted in a 27% increase in physician reimbursement for the remainder of 2015 ($2480 vs $3068/case) and a 91% increase in reimbursement from 2011 ($1601 vs $3068). Assistant surgeon reimbursement also increased ($266 vs $764). Concomitant FEVAR-related procedures generated an additional $27,347 in surgeon reimbursement. CONCLUSIONS: Physician leadership in the coding, billing, and contractual negotiations for FEVAR results in a positive medical center CM and increased physician reimbursement.
引用
- Aiello F, Durgin J, Daniel V, et al. Surgeon leadership in the coding, billing, and contractual negotiations for fenestrated endovascular aortic aneurysm repair increases medical center contribution margin and physician reimbursement. J Vasc Surg. 2017. PMID: 28390774. doi:10.1016/j.jvs.2017.01.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。